Article Versions Notes

Zhou S, Obianom ON, Huang J, Guo D, Yang H, Li Q, Shu Y. RETRACTED: Zhou et al. Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation. Pharmaceutics 2021, 13, 330. Pharmaceutics. 2023; 15(6):1623. https://doi.org/10.3390/pharmaceutics15061623

Zhou, Shiwei, Obinna N. Obianom, Jiangsheng Huang, Dong Guo, Hong Yang, Qing Li, and Yan Shu. 2023. "RETRACTED: Zhou et al. Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation. Pharmaceutics 2021, 13, 330" Pharmaceutics 15, no. 6: 1623. https://doi.org/10.3390/pharmaceutics15061623

Zhou, S., Obianom, O. N., Huang, J., Guo, D., Yang, H., Li, Q., & Shu, Y. (2023). RETRACTED: Zhou et al. Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation. Pharmaceutics 2021, 13, 330. Pharmaceutics, 15(6), 1623. https://doi.org/10.3390/pharmaceutics15061623